GlassScriptPhysician profile
Eliezer Soto
NPI 1598950990
$10,688.21
in general payments reported to CMS, 2019-2025
29 companies · $3,563 in 2025
The $3,563 reported for 2025 was more than what 88% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2020: $1,110 · 2021: $799 · 2022: $160 · 2023: $564 · 2024: $4,021 · 2025: $3,563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,882 · Travel and Lodging: $2,839 · Education: $398 · Entertainment: $29.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,881.62 |
| Travel and Lodging | $2,839.31 |
| Education | $397.50 |
| Entertainment | $29.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $3,356.49 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Boston Scientific Corporation | $2,727.13 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $1,248.00 | 2019-2025 | Proclaim, Eterna |
| Electronic Waveform Lab, INC. | $690.67 | 2019-2020 | |
| Spinal Simplicity, LLC | $661.01 | 2023-2025 | Ha Minuteman G3-R |
| Foundation Fusion Solutions, LLC | $389.86 | 2024-2025 | |
| Amgen INC. | $238.82 | 2020-2024 | Evenity, Prolia |
| Medtronic USA, INC. | $197.29 | 2019-2020 | |
| Mml US, INC. | $189.51 | 2024 | Reactiv8 |
| Nevro Corp. | $158.59 | 2021-2024 | Senza |
| Collegium Pharmaceutical, INC. | $97.57 | 2020-2021 | |
| Spr Therapeutics, INC | $78.87 | 2021-2023 | Sprint Pns System |
| Abbvie INC. | $74.90 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $73.10 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $72.76 | 2020-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $62.72 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $60.55 | 2021 | |
| Medtronic, INC. | $53.65 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $49.87 | 2020-2021 | |
| Biotronik Nro, INC. | $33.62 | 2025 | Prospera |
| Globus Medical, INC. | $32.87 | 2025 | Senza |
| Allergan, INC. | $30.70 | 2020-2021 | |
| Bioventus LLC | $25.40 | 2020 | |
| Vertos Medical, INC. | $22.38 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.88 | 2022 | |
| Fidia Pharma USA INC. | $15.61 | 2021 | |
| Uswm, LLC | $14.88 | 2021 | |
| Novartis Pharmaceuticals Corporation | $12.51 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eliezer Soto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.